Amarin to Report Third Quarter 2012 Financial Results and Host Conference Call on November 8, 2012

Amarin to Report Third Quarter 2012 Financial Results and Host Conference Call
on November 8, 2012

Conference Call Set for 4:30 p.m. ET on November 8th

BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 1, 2012 (GLOBE NEWSWIRE) -- Amarin
Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the
commercialization and development of therapeutics to improve cardiovascular
health, announced today that it will host a conference call with members of
Amarin senior management to discuss the company's third quarter 2012 financial
results and provide a business overview on Thursday, November 8, 2012, at 4:30
p.m. ET. The conference call will follow the anticipated release of Amarin's
third quarter 2012 financial results earlier that day.

To participate in the call, please dial (877) 407-8033 within the United
States or (201) 689-8033 from outside the United States. A replay of the call
will be made available for a period of two weeks following the conference
call. To hear a replay of the call dial (877) 660-6853 (inside the United
States) or (201) 612-7415 (outside the United States). A replay of the call
will also be available through the company's website shortly after the call.
For both dial-in numbers please use account number 286 and conference ID
402385. The conference call can also be heard live via the investor relations
section of the company's website at www.amarincorp.com.

About Amarin

Amarin Corporation plc is a biopharmaceutical company focused on the
commercialization and development of therapeutics to improve cardiovascular
health. Amarin's product development program leverages its extensive
experience in lipid science and the potential therapeutic benefits of
polyunsaturated fatty acids. Vascepa^TM (icosapent ethyl), Amarin's first FDA
approved product, is a patented, ultra pure omega-3 fatty acid product
comprising not less than 96% EPA. For more information about Vascepa visit
www.vascepa.com. For more information about Amarin visit www.amarincorp.com.

The Amarin Corporation plc logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=13817

CONTACT: Investor Contact Information:
         Stephen D. Schultz
         Senior Director, Investor Relations and Corporate Communications
         Amarin Corporation
         In U.S.: +1 (860) 572-4979 x292
         Direct: 908-326-1323
         investor.relations@amarincorp.com
        
         Lee M. Stern
         The Trout Group
         In U.S.: +1 (646) 378-2922
         lstern@troutgroup.com
        
         Media contact information:
         David Schull or Martina Schwarzkopf, Ph.D.
         Russo Partners
         In U.S.: +1 (212) 845-4271 or +1 (212) 845-4292 (office)
         +1 (347) 591-8785 (mobile)
         david.schull@russopartnersllc.com
         martina.schwarzkopf@russopartnersllc.com

company logo
 
Press spacebar to pause and continue. Press esc to stop.